Open AccessDiabetic neuropathy
Author(s) -
Н. В. Пизова
Publication year - 2018
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2018-18-68-75
Subject(s) - medicine , diabetic neuropathy , diabetes mellitus , pathological , polyneuropathy , peripheral neuropathy , bioinformatics , intensive care medicine , surgery , endocrinology , biology
Diabetes mellitus is one of the emergency situations worldwide. DM is the most common cause of neuropathy throughout the world that create a wide range of conditions associated with the damage of various nerves and various pathological mechanisms. The article considers the main pathogenetic mechanisms of neuropathy - the role of metabolic, vascular and genetic factors. It presents the main clinical manifestations, depending on what type of nerve fibers are affected. A modern classification of diabetic neuropathy is provided. The most common form - diabetic distal symmetric polyneuropathy is considered in detail. The authors describe the main drugs used for the treatment of diabetic neuropathy, which were proposed by the International Diabetic Federation (2017) in 2017. Lipoic acid supplements are examined in more details.